Asking Price: Offers Invited
FY 18 turnover of £2.8 million, producing an adjusted EBITDA in excess of £1 million. Forecast to achieve a turnover of £3.3 million in FY 19 with an adjusted EBITDA of £1.2 million. A rapidly growing professional advisory business, focussing on the dynamic and growing pharmaceutical market. Pipeline value of £9.8 million over the next three financial years. Gross profit margins in excess of 75%. High profile, recognised brand. Global client base comprising over 160 accounts, with 70% of revenue derived from overseas. Experienced senior management team, able to operate the company on a daily basis. Ideal diversification opportunity for a purchaser looking to enter the pharmaceutical market. Offers invited.
|Date Entered:||Login to view details|
Login to view business description
Login to view business location
We can help you capitalise on insolvent businesses. We list UK businesses in administration, liquidation and with winding up petitions daily. Ensuring our members never miss out on an opportunity
Get news on businesses for sale and companies in administration straight to your inbox